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ABSTRACT 
 
Aim: To describe the electrocardiographic (ECG) and echocardiographic manifestations of the 
paediatric athlete’s heart, and examine the impact of age, race and sex upon cardiac remodelling 
responses to competitive sport. 
 
Design: Systematic review and meta-analysis  
 
Data sources: Six electronic databases were searched to May 2016: MEDLINE, PubMed, EMBASE, 
Web of Science, CINAHL and SPORTDiscus.  
 
Inclusion criteria: 1) Male and/or female competitive athletes, 2) participants aged 6-18 years, 
3) original research article published in English language.  
 
Results: Data from 14,278 athletes and 1,668 non-athletes were included for qualitative (43 
articles) and quantitative synthesis (40 articles). Paediatric athletes demonstrated a greater 
prevalence of training-related and training-unrelated ECG changes than non-athletes. Athletes 
≥14 years were 15.8 times more likely to have inferolateral T-wave inversion than athletes <14 
years. Paediatric black athletes had significantly more training-related and training-unrelated 
ECG changes than Caucasian athletes. Age was a positive predictor of left ventricular (LV) internal 
diameter during diastole, interventricular septum thickness during diastole, relative wall 
thickness and LV mass. When age was accounted for, these parameters remained significantly 
larger in athletes than non-athletes. Paediatric black athletes presented larger posterior wall 
thickness during diastole (PWTd) than Caucasian athletes. Paediatric male athletes also 
presented with larger PWTd than females. 
Conclusions: The paediatric athlete’s heart undergoes significant remodelling both before and 
during ‘maturational years’. Paediatric athletes have a greater prevalence of training related and 
training-unrelated ECG changes than non-athletes, with age, race and sex mediating factors on 
cardiac electrical and LV structural remodelling.  
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 What is already known?  
 Chronic training loads are associated with a number of electrophysiological, structural 
and functional cardiac adaptations in adult athletes. 
 Race and sex significantly impact upon the cardiac remodelling of the adult athlete’s 
heart. 
 Paediatric athletes undergo significant growth and maturational changes; but unlike 
known musculoskeletal changes, there is limited information regarding how the heart 
may adapt to training before, during and after puberty. 
What are the new findings?  
 Paediatric athletes were up to 13 times more likely to have deep T-wave inversion (TWI) 
(≥2mm) than age-matched non-athletes 
 Paediatric athletes ≥14 years of age were up to 16 times more likely to have inferolateral 
TWI (warranting further investigation) than athletes <14 years 
 Paediatric black athletes were up to 36 times more likely to have extended anterior TWI 
(leads V1-V4) than Caucasians. 
 Even after accounting for age, left ventricular structural parameters were larger among 
paediatric athletes than paediatric non-athletes 
 
  
INTRODUCTION  
 
Regular and sustained intensive physical activity is associated with a number of 
electrophysiological1, structural and functional cardiac adaptations2; collectively referred to as 
the ‘Athlete's Heart'. It is also well documented that race and sex significantly impact these 
manifestations of the adult athlete’s heart3,4. Whilst previous systematic reviews and meta-
analyses have detailed the adult athlete’s heart phenotype2,5, with some accounting for race and 
sex6,7, data from paediatric (6-18 years) athletic populations is limited to original research; often 
restricted by inadequate sample sizes and heterogeneity to assess the impact of age, race and 
sex in tangent.  
 
Sports academies are increasingly used by clubs and governing bodies alike to develop and 
nurture talented sports stars of the future. Consequently, there is increasing competitiveness, 
professionalism and training demands placed upon the paediatric athlete during the 
maturational period.  The International Olympic Committee, amongst others, has called for more 
diligence to safeguard the physiological development of the paediatric athlete8–10. Performing a 
cardiac pre participation evaluation (PPE) within paediatric populations is controversial due to a 
lack of international consensus with regards to when, how, and who should undertake such 
examinations11,12. Whilst data from the USA indicate that paediatric black athletes are 
particularly susceptible to sudden cardiac death (SCD)13 , there is a general lack of understanding 
as to which factors (e.g., physical growth, race and sex) have the potential to increase the 
likelihood of generating a false-positive diagnosis and unnecessary disqualification from 
competitive sport. Consequently, the distinction between paediatric athlete’s heart and cardiac 
pathology associated with SCD is especially important for this population.  
 
Therefore, the primary aim of this systematic review and meta-analysis was to describe the 
electrocardiographic (ECG), structural and functional manifestations of the paediatric athlete’s 
heart compared to that of age-matched non-athletes. The secondary aims were to determine the 
impact of an athlete’s chronological age, race, and sex on cardiac remodelling responses to 
intensive competitive sport.  
 
METHODS 
 
This review was conducted and reported in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines14.  
Literature Searching  
 
A systematic search was conducted using six electronic databases; (1) MEDLINE, (2) PubMed, (3) 
EMBASE, (4) Web of Science, (5) CINAHL, and (6) SPORTDISCUS. Databases were searched from 
inception, to May 2016. Search terms were mapped to relevant MeSH terms or subject headings 
under four concepts:  
1) ‘Paediatric’ 
2) ‘Athlete’,  
3) ‘Electrocardiography’, ‘Echocardiography’, ‘Magnetic Resonance Imaging’ 
4) ‘European Society of Cardiology Criteria’, ‘Seattle Criteria’, ‘Ventricle’, ‘Atrium’ and 
‘Septum’.  
Terms within each concept were combined with the Boolean operator ‘OR’, then concepts were 
combined with the ‘AND’ operator to, produce the search strategy (Supplementary Appendix A). 
To supplement the electronic database searching, we hand searched reference lists of eligible 
articles, ePublication lists of key journals, and undertook citation tracking using Google Scholar 
(Supplementary Appendix B). All identified articles were imported into Endnote X4 for application 
of selection criteria (Thomson Reuters, California, USA). 
 
Selection Criteria 
 
Titles and abstracts of potentially eligible articles were independently screened by two authors 
(GM and NR) against the selection criteria. For articles where it was not immediately clear from 
the title and/or abstract whether they should be included, we obtained the full text for 
independent screening. Discrepancies were resolved via consensus discussion, with a third 
reviewer (MW) consulted if consensus could not be reached.  
 
Inclusion criteria were: 1) data reported for male and/or female competitive athletes, with or 
without comparison to non-athletes, 2) all participants were aged 6-18 years old at the time of 
assessment, and 3) an original research article published in English language. We defined a 
competitive athlete as: 
“One who participates in an organised team or individual sport that requires regular 
competition against others as a central component, places a high premium on excellence and 
achievement, and requires some form of systematic (and usually intense) training"15. 
Participants not meeting this definition were classified as non-athletes. Articles were limited to 
English-language owing to translation costs. Articles that did not document athlete age range 
were excluded because of the risk of including athletes >18 years. If ECG and/or 
echocardiographic outcome data were not reported, or if professional guidelines for data 
acquisition were not observed or cited, articles were also excluded. 
 
Risk of Bias Assessment 
 
We developed a 15-item risk of bias assessment checklist (Supplementary Appendix C), 
comprising items from Downs & Black’s ‘Assessment of Methodological Quality of Randomised 
and Non-Randomised Studies’ checklist16, and a previously published athletes heart meta-
analysis checklist5. The purpose was to identify articles of low methodological quality that could 
bias results17; with articles achieving ≤ 50% of total possible appraisal score, excluded from 
quantitative synthesis. Two reviewers (GM & NR) independently assessed all included articles. 
Discrepancies were resolved via consensus discussion and consistency was measured using an 
interclass correlation coefficient (ICC2,1).  
 
Data Extraction 
 
All ECG and echocardiographic data were extracted by one reviewer using a predefined 
extraction form and reviewed by a second reviewer, with discrepancies resolved by consensus 
(Supplementary Appendix D). Data extraction included the calculated mean (SD) for continuous 
data and n for dichotomous data. If insufficient data were reported, corresponding authors were 
contacted to request additional data. 
 
Data management 
 
Demographics 
 
Body surface area (BSA)18 was extracted or manually calculated from the height and body mass 
reported in individual articles. 
ECG  
 
The 2010 European Society of Cardiology (ESC) recommendations for interpretation of the 12-
lead ECG in athletes were applied,  dividing  ECG patterns into Group 1 training-related and Group 
2 training un-related patterns accordingly19. T-wave inversion (TWI) was classified if ≥1mm and 
in ≥2 contiguous leads, localised as follows: anterior leads (V1–V3), extended anterior leads (V1–
V4), inferior leads (Leads II–aVF), lateral leads (V5–V6/I–aVL) and infero-lateral leads (Leads II–
aVF/V5–V6/I–aVL). Deep TWI was defined as a negative T wave ≥2 mm in ≥2 contiguous leads, 
(excluding leads III and aVR). ECG classification of left ventricular hypertrophy (LVH) was made 
according to the Sokolow–Lyon criteria20. Early repolarisation was defined as ST segment 
elevation (0.1 mV) and/or J point elevation manifested either as QRS slurring or notching, in ≥2 
contiguous leads21.  
 
Echocardiography 
Two-dimensional echocardiography data, where the American Society of Echocardiography 
paediatric guidelines were followed, were extracted22,23. On the basis of previous publications 
within the paediatric athlete’s heart, participants with an LV wall thickness >12 mm were 
considered to have left ventricular hypertrophy (LVH)24. Left ventricular mass (LVM) was 
calculated according to the formula of Devereux25. Relative left ventricular wall thickness (RWT) 
was calculated and expressed as a fraction: [PWTd + IVSd)/LVIDd] posterior wall thickness during 
diastole (PWTd), interventricular septum thickness during diastole (IVSd) and left ventricular 
internal diameter during diastole (LVIDd). If IVSd was not reported, it was considered equal to 
PWTd2.  
 
Data synthesis  
 
Data were analysed using StatsDirect (Altrincham, UK) and Stata V.12 (Stata Corp, College Station, 
Texas, USA). Demographic data were analysed using arithmetic means. Pooled dichotomous data 
were analysed using random-effects proportion meta-analyses (as we expected significant 
statistical heterogeneity), and presented as odds ratios (ORs) or risk ratios (RRs) as appropriate. 
We only pooled data for variables with a minimum of 3 articles reporting on the variable. Pooled 
continuous data were presented as standardised mean differences (i.e. effect size). The 
magnitude of pooled standardised mean differences were interpreted according to Cohen’s 
guidelines; with small medium and large effects interpreted as ≥20%, ≥50% and ≥80% 
respectively26. A p-value of <0.05 was used to denote statistical significance. 
 
Random-effects meta-regression (Kendall’s non-parametric statistic) was utilised to explore and 
account for the impact of the covariates; age, race (black vs. Caucasian) and sex (Male vs. Female) 
upon ECG and echocardiographic variables. Random-effects meta-regression analysis was 
deemed inappropriate when ˂10 articles were available for synthesis27.  
 
Sub-analysis was used to explain the effect of the covariates; age (<14 years vs. ≥14 years), race 
(black vs. Caucasian), sex and where possible, the interaction of age (<14 years vs. ≥14 years) was 
explored within race and sex. With regards to maturational age, 14 years was set according to 
the attainment of selected development landmarks in boys (Mean age of peak height velocity = 
14; Peak weight velocity = 14.3; Peak leg length velocity = 14.4; 90% of adult stature = 13.9; 95% 
of adult stature = 14.9; Genital stage IV = 14.6; and Pubic hair stage IV = 15.1) 28 and the onset of 
menarche within females (13.2 years)29.  
 
Data were combined as per Cochrane guidelines30. If data were reported for the same 
participants in more than one article, the data were extracted from the article with the largest 
cohort size (with corresponding author’s confirmation). If an article reported multiple follow-ups, 
data were extracted from the latest visit (i.e. longest follow-up). When standard deviation (SD) 
was not reported, it was imputed from the average SD30, only utilising articles containing ≥30 
participants. To ensure results were not subsequently biased, sensitivity analysis was conducted 
omitting imputed SD data. Statistical heterogeneity was examined using the I2 index31. 
 
RESULTS 
Literature Search 
 
The literature search identified 2030 potentially eligible articles, of which 972 were duplicates. 
After application of the selection criteria, 43 articles remained for qualitative analysis and 40 
remained for quantitative analysis (Figure 1).  
<INSERT FIGURE 1 HERE>  
Risk of bias assessment 
 
There was substantial agreement (71% 95% CI (49-84))32 between the reviewers for the risk of 
bias assessment (Supplementary Appendix E). Most frequently, discrepancies occurred when 
assessing ‘professional guidelines’ and ‘missing data’ (77% 95% CI 61-68)). Risk of bias scores 
ranged from 4 to 13 out of a maximum possible score of 15. No articles reported ‘power analysis’ 
or ‘intra-observer reliability’, with non-athlete ‘activity levels’ poorly described in 44%. Three 
articles were excluded33–35 from quantitative synthesis due to low methodological quality.   
 
Demographic data 
 
Data from 14,278 athletes (mean age 13.8 ± 1.3 years [range: 6-18]) and 1,668 non-athletes 
(mean age 12.6 ± 0.6 years [7-18]) were extracted from 43 articles. There were no differences in 
age or BSA between paediatric athletes and non-athletes. Athletes competed in 30 different 
sports, with football (soccer) predominating (33%). There were more males and Caucasians, but 
proportionately distributed among both athletes and non-athletes. In 2 articles, sex was not 
reported35,36. In 23 articles, race was not documented33–56 and in 29 articles maturational status 
was not reported24,33–46,49,50,53,55–67 (Table 1).   
<INSERT TABLE 1 HERE > 
 
Data management  
 
Within the 40 articles that were quantitatively synthesised; two articles reported overlapping 
data from a group of 155 athletes58,62, two articles reported overlapping data from a cohort of 
158 athletes43,44 and two articles reported overlapping data from a cohort of 900 athletes24,68.  
Four articles presented multiple follow-up data40,59,64,69. Adjustments were made, to account for 
this in the meta-analysis (Supplementary Appendix F). 
 
Electrocardiographic characteristics 
 
Paediatric athlete vs. paediatric non-athlete 
 
Paediatric athletes had a significantly longer PR interval, and a significantly greater frequency of 
sinus bradycardia, 1st ⁰AV block, incomplete right bundle branch block (IRBBB), voltage criteria 
for LVH and early repolarisation when compared to paediatric non-athletes (Table 2). The 
prevalence of TWI ≥1mm was similar between athletes and non-athletes (6.7% vs. 5.9%). 
However, athletes were 12.7 times more likely to have deep TWI ≥2 mm in ≥2 contiguous leads 
(except leads III and aVR) than non-athletes (4.7% vs. 0.3%). Athletes were 1.4 times more likely 
to have anterior TWI (6.5% vs. 5.7%) and 1.5 times more likely to have extended anterior TWI 
(1.4% vs. 0.9%) than non-athletes. Whilst inferior (0.9%) and lateral (0.2%) TWI was present 
among athletes, these were not observed in non-athletes. Other training un-related ECG patterns 
suggestive of underlining cardiac pathology including ST segment depression, abnormal Q waves, 
complete bundle branch blocks and abnormal QTc measurements were rarely observed in 
athletes (≤0.6%) and were not observed in non-athletes. 
<INSERT TABLE 2 HERE> 
 
Impact of paediatric athlete age 
 
Paediatric athletes ≥14 years had a significantly longer QRS duration, and a significantly greater 
frequency of sinus bradycardia and voltage criteria for LVH than athletes <14 years (Table 3). 
Athletes ≥14 years were 1.3 times more likely to have TWI than athletes <14 years (6.9% vs 5.4%). 
Athletes <14 years were 1.2 times more likely to have anterior TWI than athletes ≥14 years (6.7% 
vs. 5.4%). Athletes ≥14 years were 3.1 times more likely to have extended anterior TWI (1.7% vs. 
0.5%), and 15.8 times more likely to have inferolateral TWI (2.5% vs. 0.1%) than athletes <14 
years.   
<INSERT TABLE 3 HERE> 
 
Impact of paediatric athlete race 
 
Black paediatric athletes had a significantly greater frequency of sinus bradycardia, 1st ⁰AV block, 
IRBBB, voltage criteria for LVH and early repolarisation compared to Caucasian athletes (Table 4).  
Black athletes were 4 times more likely to have TWIs (23.4% vs. 5.9%) and 2.6 times more likely 
to have deep TWIs (10.6 vs. 4.2%), than Caucasian athletes. Further, black athletes were 2.9 times 
more likely to have anterior TWI (12.2% vs. 4.2%), 36 times more likely to have extended anterior 
TWI (10.8% vs. 0.3%) and 6.5 times more likely to have inferolateral TWI (8.2% vs. 1.3%) than 
Caucasian athletes.  Finally, black athletes were 5 times more likely to have abnormal Q waves 
(0.5% vs. 0.1%) and 2.9 times more likely to have LAE (5.7% vs. 2.0%) when compared to 
Caucasian athletes.  
<INSERT TABLE 4 HERE> 
 
Echocardiographic patterns 
Paediatric athletes vs paediatric non-athletes 
 
Athletes had a significantly greater LVIDd (+8.2%), LVID during systole (LVIDs) (+14.2%), IVSd 
(+12.9%), PWTd (+12.2%), relative wall thickness (RWT), (+5.6%) LV mass (LVM) (+27.6%), and 
left atrial diameter (LAD) (+12.3%) than non-athletes (Table 5). One percent of athletes (95% CI 
0.3 - 2.3, 5 articles; n=4460) had LVH (LV wall thickness >12 mm). LVH was not observed in non-
athletes. There were no significant differences in cardiac functional parameters between athletes 
and non-athletes. Using imputed SDs did not influence the results.  
<INSERT TABLE 5 HERE> 
 
Impact of age: paediatric athletes vs paediatric non-athletes 
 
Age was a positive predictor of LVIDd, IVSd, PWTd, RWT and LVM in athletes and non-athletes 
(P≤0.001). After accounting for age, athletes had greater LVIDd, IVSd, RWT and LVM (P≤0.05) 
than non-athletes.  
Impact of paediatric athlete age 
 
Paediatric athletes ≥14 years had a significantly greater LVIDd (+13.5%), LVIDs (+15.9%), IVSd 
(+15.2%), PWTd (+21.3%), LVM (+38.7%), Aortic Root (+14.2%), and LAD (+15.6%) than athletes 
<14 years (Table 6). With the exception of E/A ratio (+13.6% greater in athlete’s ≥14 years) there 
were no statistical differences with regards to left ventricle function.  
<INSERT TABLE 6 HERE> 
 
Impact of paediatric athlete race 
 
Black athletes had a significantly greater PWTd (+12.4%) and LAD (+13.4%) than Caucasian 
athletes (Table 7). Prevalence of LVH (LV wall thickness >12 mm) was 17.1 times greater among 
black [2 articles, n=319] than Caucasian athletes [3 articles, n=3318] (7.1% vs. 0.4%).  
<INSERT TABLE 7 HERE> 
 
Impact of paediatric athlete sex 
 
Male athletes had a significantly larger IVSd (+9.2%) than female athletes (Table 8). Prevalence 
of LVH was 2.6 times greater among male [5 articles; n=4028) than female athletes [2 articles; 
n=432] (1.2% vs. 0.4%).  
<INSERT TABLE 8 HERE> 
 
DISCUSSION  
  
In the first systematic review and meta-analysis investigating the ECG, structural and functional 
manifestations of the paediatric athlete’s heart, we found that 1) Paediatric athletes had a 
greater prevalence of training-related and training unrelated ECG changes than non-athletes, 2) 
Whilst the overall prevalence of TWI remained similar, the distribution and magnitude differed; 
3) Paediatric athletes had larger echocardiographic derived LV dimensions than non-athletes, 
even after accounting for age; 4) Paediatric black athletes had increased levels of training and 
training unrelated ECG findings (particularly TWI); and finally 5) Paediatric black athletes had a 
greater prevalence of echocardiographic derived indices of LVH compared to Caucasian athletes.  
ECG characteristics of the paediatric athlete  
 
This study confirms that regular and prolonged physical training is associated with a high 
prevalence of bradycardia, repolarisation changes, atrial enlargement and ventricular 
hypertrophy in paediatric athletes70. However, the magnitude, prevalence and distribution of 
such changes are dependent on the chronological age of the paediatric athlete. Similar to adult 
athletes, race impacted ECG remodelling in the paediatric athlete71. Black paediatric athletes had 
significantly more training-related changes, anterior, extended anterior, inferolateral and deep 
TWIs, in addition to Q waves and LAE compared to Caucasian athletes6. 
 
T wave inversion in the paediatric athlete: impact of age and race 
 
Inverted T-waves may represent the only sign of an inherited heart muscle disease even in the 
absence of any other features or before structural changes in the heart can be detected63. Yet, 
until complete formation of adult ventricular mass, T wave inversions may persist across leads 
V1-V3 within the paediatric population, owing to right ventricular dominance72. Our findings on 
over 9000 paediatric athletes and over 800 paediatric non-athletes, support this notion, with a 
relatively high, but similar prevalence of anterior TWI (V1-V3) observed in both athletes and non-
athletes (6.5% vs. 5.7%) respectively; suggesting this is a maturational trait largely not resultant 
upon athletic training. The slightly higher prevalence of anterior TWI in athletes vs. non-athletes 
also suggests that regular exercise may exacerbate or prolong the presence of juvenile TWI. 
Nevertheless, paediatric athletes were 12.7-times more likely to present with deep TWI (≥2mm) 
than non-athletes. Deep TWI (≥2mm) in the precordial leads are a major concern as these ECG 
alterations are a recognised manifestation of hypertrophic cardiomyopathy and arrhythmogenic 
right ventricular cardiomyopathy73.  
 
TWIs are uncommon among adult Caucasian athletes. Conversely, African/Afro–Caribbean black 
athletes have a higher prevalence of TWI, as well as more striking repolarisation changes and 
magnitude of voltage criteria for LVH than Caucasian athletes of similar age and size participating 
in identical sports74,75. Similar to their adult counterparts76, we found that black paediatric 
athletes are 4 times more likely to exhibit any TWI and 36 times more likely to exhibit extended 
anterior TWI (V1-V4) than Caucasian paediatric athletes63; this likely represents an ethnic 
response to physiological adaptation to exercise rather than an effect of race alone, exuberated 
by right ventricular dominance during pubertal years. 
 
When is anterior T-Wave inversion normal?  
 
Recently updated international consensus standards for 12-lead ECG interpretations in 
athletes77,78 recommends that TWI ≥ 1 mm in depth in two contiguous anterior leads (V2-V4) is 
abnormal (with the exception of TWI confined to leads V1-V4 in black athletes and leads V1-V3 
in all athletes aged <16 years) and should prompt further evaluation for underlying structural 
heart disease. Our data support this recommendation, demonstrating a significantly reduced 
prevalence of anterior TWI (V1-V3) in athlete’s ≥14 years likely as a consequence of maturation. 
Based on current evidence, TWI in the anterior leads (V1-V3) in paediatric athletes <14 years of 
age (or pre-pubertal athletes) should not prompt further evaluation in the absence of symptoms, 
signs or a family history of cardiac disease.  
 
Our data also support the observation that like their adult counterparts, paediatric black athletes 
were 3 times more likely to have anterior TWI (V1-V3) and 36 times more likely to have extended 
anterior TWI (V1-V4) when compared to Caucasians. In adult black athletes, it is recognised that 
anterior TWI is a normal variant when preceded by J-point elevation and convex ST segment 
elevation79, unlike in arrhythmogenic right ventricular cardiomyopathy where the J-point and/or 
ST segment is usually isoelectric or depressed prior to TWI. Appreciating the J-point and 
preceding ST segment may help differentiate between physiological adaptation and 
cardiomyopathy in athletes with anterior TWI affecting leads V3 and/or V4, and may prove to be 
especially useful in athletes of mixed race. A recent study compared black and Caucasian healthy 
athletes against hypertrophic cardiomyopathy and arrhythmogenic right ventricular 
cardiomyopathy patients, all of whom had anterior TWI. Within athletes, the combination of J-
point elevation ≥1mm and TWI confined to leads V1-V4 excluded hypertrophic cardiomyopathy 
or arrhythmogenic right ventricular cardiomyopathy with 100% negative predictive value, 
regardless of race79. Conversely, anterior TWI associated with minimal or absent J-point elevation 
(<1 mm) may reflect a cardiomyopathy. Such detailed investigations have yet to be extended to 
the paediatric athletic population. 
 
Inferior and/or lateral TWI warrants investigation 
 
We were surprised by the high prevalence of inferolateral TWI in both black (8.5%) and Caucasian 
(1.3%) paediatric athletes. It is unlikely that all such athletes harbour a sinister cardiomyopathy 
and may represent a racial variant in black athletes. Despite this, lateral lead TWI should be 
viewed with caution. We recently investigated 155 athletes presenting with pathological TWI 
with clinical examination, ECG, echocardiography, exercise testing, 24h Holter ECG and cardiac 
magnetic resonance80. Cardiac disease was established in 44.5% of athletes (81% hypertrophic 
cardiomyopathy). Inferior and/or lateral TWI were the most commonly observed ECG 
abnormalities (83.9%) and were largely isolated findings without other ECG abnormalities 
(43.2%). In our experience, regardless of an increased frequency after 14-years and a higher 
prevalence in adolescent black athletes, inferolateral TWI should be considered pathological in 
all cases until proven otherwise. While exclusion from competitive sport is not warranted in the 
asymptomatic paediatric athlete without a family history of SCD and normal secondary 
examinations, annual follow-up is essential to ascertain possible disease expression.  
 
Left ventricular morphology of the paediatric athlete 
 
While most adult athletes have left ventricular structural changes that are considered 
physiological, there are a small proportion who develop pronounced morphological changes that 
overlap with phenotypic expressions of cardiac pathology associated with SCD. Several groups 
have produced algorithms to aid in this differentiation81–83. Data for these algorithms primarily 
derives from five large echocardiographic studies75,84–87 examining 5053 elite, predominately 
male adult athletes; 134 (2.7%) had a maximal wall thickness ≥12 mm (of which 27 (0.5%) athletes 
had a maximum wall thickness of ≥13 mm). In absolute terms and regardless of an athlete’s BSA, 
the upper limit of physiological hypertrophy for adult male athletes is considered ≥13 mm for 
maximal wall thickness and ≥65 mm for LVIDd.  
 
Despite undergoing significant changes in anthropometry during maturation paediatric athletes 
have significantly larger cardiac diameters, wall thicknesses and LV mass than non-athletes even 
after adjusting for age. From 4460 paediatric athletes analysed, just 1.1% presented with a 
maximal wall thickness ≥12 mm; although a maximal wall thickness of 15mm was documented 
in one study. A pooled mean LVIDd of 47mm (<14 years: 44.2mm vs. ≥ 14 years: 51.1 mm) is 
similar to upper limits previously observed among paediatric hypertrophic cardiomyopathy 
patients (48mm)88. Thus, such adult upper limit criteria may not be applicable to the paediatric 
athlete. Regardless of race, values above these should be viewed with suspicion in paediatric 
athletes, particularly if the athlete also presents with cardiac symptoms, a family history of SCD 
and/or an abnormal ECG.  Given the widely recognised impact of chronological age and somatic 
growth upon paediatric echocardiographic variables, it is our suggestion that Z scores (which 
account for the effects of body size and chronological age) are instead used for differential 
diagnosis when normative data are available89–91, as previously suggested within paediatric 
specific echocardiographic guidelines22.  
 
Impact of chronological age on LV remodelling 
 
Cardiac enlargement increased with chronological age, as demonstrated by our meta-regression 
as well as by others92, and helps to explain the heterogeneity observed within this dataset. After 
accounting for age (using meta-regression), paediatric athletes had greater LV morphology than 
paediatric non-athletes, demonstrating the potent stimulus exercise has upon cardiac structure. 
These changes appeared to be exaggerated during the pubertal growth stage, suggesting a 
potential role of hormonal factors in cardiac remodelling93.  We recognise that whilst chronologic 
age is a linear factor, growth and maturation are not94, and thus maturational status for children 
of the same chronological age can differ dramatically95,96. Yet, assessment of maturational status 
was conducted among only 14 of the 43 (33%) articles included for qualitative synthesis, and 
relied largely on assessment by Tanner Scale (79%), regarded to be inappropriate by many due 
to obvious child protection concerns. In our experience, clinical interpretation of cardiac PPE data 
should be governed by biological age rather than chronological age.  According to the 
International Olympic Committee consensus statement on youth athletic development97, 
skeletal age is the most useful estimate of maturity status and can be used from childhood into 
late adolescence. However, this can only be confirmed by radiological hand-wrist imaging. Since 
this is not widely available in most cardiological units, alternative simple measures such as 
percentage of predicted mature (adult) height at the time of observation may provide an 
estimate of maturity status98. However care is warranted, as 1) predicted mature (adult) height 
only demonstrates moderate concordance with classifications of maturity status, based on 
skeletal age99,100, and 2) historical height data of the patient is required to rule out sudden growth 
spurts. 
 
Impact of race on LV remodelling 
 
Data from the USA indicate that paediatric black athletes are particularly susceptible to SCD13, 
and therefore, the distinction between athlete’s heart and cardiac pathology is of particular 
relevance in this group. Consistent with previous observations in adults75,101,102, we found that 
paediatric black athletes had increased LVH in response to chronic training loads compared to 
Caucasian athletes. This change is consistent with a concentric remodelling pattern. 
Furthermore, the likelihood of LVH was 17.1 times greater among black when compared to 
Caucasian athletes. We speculate that these ethnic-specific manifestations of the athlete’s heart 
are the result of hemodynamic influences; specifically greater peripheral vascular resistance and 
a smaller nocturnal decline in BP100.  
 Impact of sex on LV remodelling  
 
The last three decades have witnessed an exponential rise in the number of females participating 
in high-level competitive sport105. Consistent with observations among adults4, we found a 
reduced LVH  response to chronic training loads in female athletes compared to males. This might 
be due to hormonal differences and lower testosterone concentrations106. However, the relative 
differences of sex across maturational years has yet to be fully elucidated among paediatric 
athletes. Females reach complete pubertal development at an earlier chronological age and thus 
we may expect such relative differences between female and male athletes to be smaller during 
the early stages of pubertal development.   
 
Limitations  
 
A high statistical heterogeneity (I2) was observed; this may be because it was not possible to 
stratify data according to biological age, race or sex due to inconsistent methodology and designs 
implemented within the observational studies included. Because of this, a random-effects meta-
analysis model was adopted to provide a more conservative pooled estimate. Activity levels of 
our non-athlete cohort are unknown and thus they may not actually be sedentary, however, in 
all cases, participants did not meet classification criteria for a competitive athlete.  
 
Whilst we utilised the 2010 ESC recommendations for interpretation of the 12-lead ECG19, at the 
time of publication, it was not intended to be used in athletes ≤12 years old. We recently 
observed that the 2014 ‘Refined Criteria’ for ECG interpretation in athletes outperformed both 
the 2013 Seattle Criteria and the 2010 ESC recommendations, by significantly reducing the 
number of false-positive ECGs in Arabic, Black and Caucasian adult athletes while maintaining 
100% sensitivity for serious cardiac pathologies107. Again, however, all three ECG criteria are only 
applicable for adult athletes and not paediatric athletes. Thus for paediatric cardiac PPEs, the 
attending cardiologist or sports medicine physician is left with the conundrum of which criteria 
should be used for ECG interpretation. Recently published International consensus standards for 
ECG interpretation in athletes77 do account for age and race respectively. TWI in the anterior 
leads (V1-V3) in adolescent athletes <16 years of age (or pre-pubertal athletes) and black adult 
athletes with J-point elevation and convex ST segment elevation followed by TWI in V2-V4, would 
now not prompt further evaluation in the absence of symptoms, signs or a family history of 
cardiac disease. But in most non-black athletes age ≥ 16 years, anterior TWI beyond lead V2 
would prompt further evaluation given the potential overlap with arrhythmogenic right 
ventricular cardiomyopathy.  
 
Finally, echocardiographic data were largely limited to left ventricle structural variables, owing 
to insufficient data available for synthesis. Such limitations highlight the importance of further 
research in the paediatric athlete extending to other chambers of the heart, and beyond load 
dependent measurements of cardiac function (ejection fraction or fractional shortening) towards 
Tissue Doppler imaging and myocardial deformation (strain) imaging.  
Conclusion  
 
Similar to adult athletes, paediatric athletes had a greater prevalence of training related and 
training unrelated ECG changes than non-athletes. Significant cardiac remodelling in paediatric 
athlete occurs both before and during their ‘maturational years’; with race and sex significantly 
impacting upon the pattern of remodelling observed. The results demonstrate the importance of 
adjusting for age when assessing LV morphology in paediatric athletes, whilst consideration for 
an athletes’ race and sex is further required when differentiating between physiological and 
pathological cardiac remodelling.  
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Table 1 Article characteristics    
 Athletes Non-Athletes Outcome 
data 
Author, year n Chronological 
age 
Mean (range) 
Biological 
age 
Race 
(C:B:O) 
Sex 
(M:F) 
Sport n Chronological 
age 
Mean (range) 
Biological 
age 
Race 
(C:B:O) 
Sex 
(M:F) 
ECG ECHO 
Agrebi 201567  24 13.9 (11-17) NR 0:0:24 24:0 Handball        
Attisani 201133 1865 13.7 (6-18) NR NR 1865:0 Soccer/Gymnastics      Y N 
Ayabakan 
2006108 
22 11.0 (9-12) Prepubertal 22:0:0 22:0 Swimming 21 10.7 (9-12) Prepubertal 21:0:0 21:0 N Y 
Bartkevičienė 
201556 
167 14.8 (12-17) NR NR 167:0       N Y 
Bessem 201457 193 14 (10-19) NR 134:29:30 193:0 Soccer      Y N 
Calò 2015109 2261 12.4 (8-18) Peripubertal 2261:0:0 2261:0 Soccer      Y Y 
Csajági 201569 18 13.7 (13-15) Mid 
pubertal 
18:0:0 8:7 Swimming 15 13.8 (13-15) Mid 
pubertal 
15:0:0 8:7 N Y 
Di Paolo 
201258 
216 16.1 (14-18) NR 63:153:0 216:0 Soccer      Y Y 
Dinu 201035 40 12.7 (10-17) NR NR NS Athletics      N Y 
Hauser 201337 26 12.6 (7-17) NR NR 18:8 Triathlon      N Y 
Hoogsteen 
200338 
66 17.5 (17-18) NR NR 66:0 Cycling      N Y 
Kinoshita 
201559 
34 16.5 (16-17) NR 0:0:34 0:34 Middle / long-distance 
runners 
     N Y 
Koch 201239 343 13 (10-15) NR NS 189:154 High school athletes      Y Y 
Konopka 
201560 
78 14.3 (12-17) NR 78:0:0 64:14 Soccer, Tennis, Rowing.      N Y 
Madeira 
200853 
21 15.9 (15-16) NR NR 21:0 Soccer; Swimming      N Y 
Makan 200568 900 15.7 (14-18) Post 
pubertal 
 
882:0:18 693:207 10 sporting disciplines 
(Invasion games/ racket/ 
endurance/combat) 
250 15.5 (14-18) Post 
pubertal 
 
NR 177:48 N Y 
Medved 
198636 
72 10 (8-14) NR NR NR Swimming 72 10 (8-14) NR NR NS N Y 
Meško 199340 23 14.5 (14-15) NR NR 23:0 Hockey 17 14.5 (14-15) NR NR 17:0 N Y 
Migliore 
2012110 
2765 13.9 (8-18) Peri 
pubertal 
 
2765:0:0 1914:851 18 sporting disciplines 
(Invasion games/ 
gymnastics/winter 
sports/horse-
riding/racket/ 
endurance/combat) 
     Y N 
Moarles 
199234 
9 16.2 (14-17) NR NR 9:0 Basketball      N Y 
Obert 199841 10 10.7 (10-11) Pre pubertal 
 
NR 4:6 Swimming 
 
11 10.9 (10-11) Prepubertal 
 
NR 4:7 N Y 
Ozer 199442 82 11.2 (7-14) NR NR 41:41 Swimming 41 10.8 (7-15) NS NR 22:19 N Y 
Papadakis 
2009111 
1710 16 (14-18) Post-
pubertal 
 
1642:0:0 1414:291 15 sporting disciplines 
(Invasion games/ racket/ 
endurance/combat) 
400 16 (14-18) Post 
pubertal 
 
385:0:0 330:70 Y N 
Pavlik 2001112 165 14.7 (10-18) NR 165:0:0 165:0 7 sporting disciplines 
(Endurance/invasion 
games/weightlifting) 
22 14.7 (10-18) NR 22:0:0 22:0 N Y 
Pelà 201443 138 14.3 (11-17) NR 96:42:0 138:0 Soccer      Y Y 
Pelà 2015 44 206 13.8 (11-17) NR 206:0:0 158:48 Soccer      Y Y 
Petridis 200461 137 16.6  (15-18) NR NS 137:0 Swimming      N Y 
Rowland 1987 
45 
14 11 (8-14) Prepubertal NR 14:0 Swimming 19 10.4 (8 -13) Prepubertal NR 19:0 Y Y 
Rowland 
199446 
10 12.2 (11-13) Prepubertal NR 10:0 Middle distance runners 18 11.3 (10–14) Pre 
pubertal 
NR 18:0 Y Y 
Rowland 
199747 
9 12.2 (9-15) Early 
pubertal 
NR 9:0 Cyclists      N Y 
Rowland 
200048 
8 11.9 (10-13) Early 
pubertal 
NS 8:0 Cyclists & Triathletes 39 12.2 (10-13) Early 
pubertal 
NR 39:0 N Y 
Schmied 
200962 
155 16.4 (14-17) NR 0:155:0 155:0 Soccer      Y Y 
Sharma 199970 1000 15.7 (14-18) Post-
pubertal 
 
998:8:4 730:180 9 Sporting disciplines 
(Invasion games/ racket/ 
endurance/combat) 
300 15.6 (14-18) Post 
pubertal 
 
293:0:7 210:90 Y N 
Sharma 200224 720 15.7 (14-18) NR 706:14:0 540:180 10 Sporting disciplines 
(Invasion games/ racket/ 
endurance/combat) 
     N Y 
Sheikh 201363 1232 16.4 (14-18) NR 903:329:0 980:252 Swimming/Athletics 134 15.3 (14–18) NR 0:134:0 88:46 Y Y 
Shi & Selig 
200549 
13 15.3 (14-16) NR NR 13:0 Gymnastics/Swimmers      N Y 
Stoner 199764 37 9.9 (7-11) NR NR 0:37 Athletics 22 9.1 (7-11) NR NR 0:22 N Y 
Sundberg & 
Elovainio 
198250 
59 13.7 (10-17) NR NR 59:0 Athletics 81 13.9 (10-17) NR NR 81:0 Y N 
Telford 198851 85 11.9 (11-12) Pre-mid 
pubertal 
NR 48:37 Hockey 106 12.3 (12-13) Pre-mid 
pubertal 
 60:46 N Y 
Valente-Dos-
Santos 201352 
73 15.4 (15-17) Skeletal age 
16.4 
NR 73:0 Basketball      N Y 
Vasiliauskas 
200665 
62 13.6 (8-17) NR 62:0:0 62:0 Soccer      N Y 
Yildirim 201655 140 14.3 (10-18) NR NS 107:33 Basketball, Soccer, 
Swimmers. 
31 14.1 (10-18) NR NR 21:10 Y Y 
Zdravkovic 
2010 66 
94 12.9 (12-14) NR 94:0:0 94:0 Soccer 47 12.9 (12-14) NR 47:0:0 47:0 N Y 
Abbreviations: C, Caucasian; B, Black; O, Other; M, Male; F, Female; NR, Not reported; Y, Yes; N, No. 
Table 2 ECG characteristics of Paediatric athletes and Paediatric non-athletes 
Characteristics Athletes Non-athletes % Difference 
PR interval (ms) 
 
148 (142 – 154)* 
[10; 5671] {98%} 
139 (136- 141)  
[4; 737] {41%} 
6.1% 
QRS duration (ms) 86 (84 -88) 
[11; 6938] {97%} 
83 (79 -86) 
[6; 952] {97%} 
4% 
QTc duration (ms) 396 (391-400) 
[11; 7018 ] {97%} 
386 (375 - 398) 
[6; 902] {97%} 
3% 
QRS axis*, (degrees) 70 (63.1 - 76.1) 
[8; 5476] {99%} 
70 (67.9 - 73.0) 
[4; 779] {60%} 
0% 
Group 1 ECG patterns Odds Ratio 
Sinus bradycardia (%)  37.4 (17.6 – 59.7)** 
[11; 9745] {99%} 
19.2 (16.6 21.90) 
[3; 834] {0%} 
2.5 (2.1 - 3.0) 
Sinus arrhythmia (%) 45.8 (35.7 -56.0) 
[3; 2898] {95.9%} 
  
1st ⁰AV block (%) 2.2 (0.8 - 4.2)** 
[8; 9488] {97%} 
0.4 (0.1 - 1.1) 
[3; 834] {26%} 
4.6 (1.7 - 12.4) 
2nd ⁰AV block (Morbitz 
Type I) (%) 
0.2 (0.1 - 0.4) 
[3; 2898} {0%} 
  
Incomplete RBBB (%) 25.8 (18.2 - 33.7)** 
[10; 9736] {97%} 
7.8 (4.2 - 12.4) 
[3; 834] {78%} 
4.3 (3.5 – 5.6)  
LVH (%) 35.2 (26.0 - 45.0)** 
[11; 9745] {98%} 
24.1 (20.3 - 28.1) 
[3; 834] {41%} 
1.7 (1.5 - 2.0) 
ER (%) 37.1 (25.6 -49.2)** 
[10; 9736] {99.3%} 
29.2 (17.2 – 43.0) 
[3; 834] {93.9%} 
1.4 (1.2 -1.7) 
Group 2 ECG patterns Risk Ratio 
TWI (≥1mm) (%) 6.7 (4.7 - 8.9) 
[7; 9372] {93.3%} 
5.9 (2.2 – 11.2) 
[3; 834] {86.7%} 
1.1 (0.8 – 1.5) 
Deep TWI (≥2mm) (%) 4.7 (2.3 - 8.1)** 
[7; 6514] {95.9%} 
0.3 (0.04 - 1.8) 
[2; 534] {60.3%} 
12.7 (3.1 – 50.7) 
Anterior (%) 6.5 (2.9 - 11.3) 
[7; 9372] {98.4%} 
5.7 (2.2 - 10.6) 
[3; 834] {84.9%} 
 
1.2 (0.9 – 1.5) 
Extended 
Anterior (%) 
1.4 (0.2 - 3.5) 
[4; 5391] {95.8%} 
0.9 (0.2 - 2.2) 
[2; 534] {24.1%} 
1.5 (0.6 – 3.6) 
Inferior (%) 1.0 (0.3 - 2) 
[5; 7446] {93%} 
0.0 
[3; 834] 
NC 
Lateral  (%) 0.3 (0.05 - 0.6) 
[5; 7446] {80%} 
0.0 
[3; 834] 
NC 
Infero-lateral 
(%) 
2.0 (1.0 – 3.3) 
[8; 9256]  {93%} 
0.0 
[3; 834] 
NC 
ST-segment depression 
(%)  
0.03 (0.003 - 0.08) 
[6; 7615] {0%} 
0.0 
[3; 834] 
NC 
Abnormal Q waves (%) 0.1 (0.03 - 0.2) 
[10; 9902] {25%} 
0.0 
[3; 834] 
NC 
LAE (%) 3.5 (0.4 - 9.5) 
[8; 5804] {98%} 
  
RAE (%) 5.9 (0.9 - 14.8) 
[4; 2575] {98%} 
  
LAD (%) 0.4  (0.1 - 0.9) 
[6; 5683] {75%} 
  
RAD (%) 3.7 (0.1 -11.8) 
[5; 4352] {98%} 
  
RVH (%) 9.8 (7.0 -13.0) 
[3; 2420] {81%} 
  
Ventricular pre-
excitation (%) 
0.6 (0.2 - 1.1) 
[6; 7422] {79%} 
  
Complete RBBB (%) 0.5 (0.3 - 0.7) 
[8; 9715] {55%} 
0.0 
[3; 834] 
NC 
Complete LBBB (%) 0.1 (0.008 - 0.3) 
[7; 9499] {81%] 
0.0 
[3; 834] 
NC 
Long QT interval (%) 0.6 (0.1 - 1.3) 
[9; 10247] {57%} 
0.0 
[3; 834] 
NC 
Short QT interval (%) 0.4 (0.02 - 1.1) 
[4; 4108] {81%} 
0.0 
[3; 834] 
NC 
Brugada-like ER (%) 0.2 (0.03- 0.4) 
[5; 7079] {0%} 
  
Data are presented mean or percentage (95%CI) [number of articles; number of participants] 
{heterogeneity} 
*p ≤0.05 Significantly greater or more prevalent in athletes than non-athletes 
 ** p ≤0.001 Significantly greater or more prevalent in athletes than non-athletes 
NC: Non-Computable 
Abbreviations: AV, atrioventricular; RBBB: right bundle branch block; LVH: left ventricular 
hypertrophy; ER: early repolarisation; TWI: T-wave inversion; Anterior: V1–V3; Extended Anterior: 
V1–V4; Inferior: Leads II-aVF; Lateral: V4-V6/I-aVL; Infero-lateral: Leads II-aVF/V4-V6/I-aVL; LAE: left 
atrial enlargement; RAE: right atrial enlargement; LAD: left axis deviation; RAD: right axis deviation; 
LBBB: left bundle branch block 
 
 
 
 
 
  
Table 3 ECG characteristics of Paediatric athletes: Impact of Age  
Characteristics ≥14 years ˂14 years % Difference 
PR interval (ms) 151 (140 - 162)  
[4; 1985] {99%} 
142 (137 - 147) 
[4; 89] {58%} 
6% 
QRS duration (ms) 92 (91 -93)* 
[4; 1991] {59%} 
74 (70 - 82) 
[3; 77] {88%} 
9% 
QTc duration (ms) 377 (354 - 400) 
[5; 4205] {99%} 
394 (375 -  412) 
[3; 77] {6%} 
-5% 
QRS axis*, degree 76 (73 - 78) 
[4; 2816] {89%} 
74.7 (61.4 - 88.0) 
[2; 63] {75%} 
2% 
Group 1 ECG patterns Odds Ratio 
Sinus bradycardia (%)  61.3 (46.3 - 75.3)** 
[5; 4205] {98%} 
18.8 (12.1 - 26.7) 
[2; 109] {0%} 
6.6 (4.1-10.7) 
LVH (%) 48.0 (36.4 - 59.5)** 
[5; 4205] {98%} 
20.7 (9.3 – 35.1) 
[2; 109] {30%} 
3.4 (2.2 -5.5) 
Group 2 ECG patterns Risk Ratio 
TWI (≥1mm) (%) 6.9 (3.7 - 10.9** 
[6; 5051] {96%} 
5.4 (0.2 - 16.9) 
[2; 1272] {92%} 
1.3 (1.0-1.7) 
Anterior (%) 5.4 (1.4 - 11.8) 
[7; 6575] {98%} 
6.7 (4.4 – 9.4)† 
[3; 2516] {78%} 
1.2 (1.0 - 1.5) 
Extended 
Anterior (%) 
1.7 (0.4 – 4.0)* 
[4; 3823] {94%} 
0.5 (0.1 - 3.0) 
[2; 1257] {68%} 
 
3.1 (1.4 – 6.6) 
Infero-lateral 
(%) 
2.5 (1.0 - 4.6)** 
[5; 3710] {89%} 
0.1 (0.01 - 0.4) 
[2; 1272] {0%} 
15.8 (3.9 – 63.9) 
Data are presented mean or percentage (95%CI) [number of articles; number of participants] 
{heterogeneity} 
*p ≤0.01 Significantly greater or more prevalent in athletes ≥14 years than in athletes ˂14 years 
** p ≤0.001 Significantly greater or more prevalent in athletes ≥14 years than in athletes ˂14 years 
† ≤0.05 Significantly greater or more prevalent in athletes <14 years than in athletes ≥14 years 
NC: Non-Computable 
Abbreviations: LVH: left ventricular hypertrophy; TWI: T-wave inversion; Anterior: V1–V3; Extended 
Anterior: V1–V4; Infero-lateral: Leads II-aVF/V4-V6/I-aVL. 
 
 
  
 Table 4 ECG characteristics of Paediatric athletes: Impact of race  
Characteristics Black (10-18 years) Caucasian (8-18 years) % Difference 
PR interval (ms) 
 
161 (146 -177) 
[2; 196] {91.6%} 
141 (135 to 148) 
[3; 2529] {95%} 
12% 
QRS duration (ms) 86 (82 - 90)** 
[3; 525] {94.9%} 
92 (88 - 95) 
[4; 3232] {98.3%} 
-7% 
QTc duration (ms) 394 (387 - 401) 
[3; 525] {95%} 
398 (392 - 403) 
[4; 3232] {98.4%} 
-1% 
Group 1 ECG patterns Odds Ratio 
Sinus bradycardia (%) 38.2 (18.6 - 60.1)*** 
[3; 525] {95%} 
29.3 (10.9 -  52.2) 
[5; 6197] {99%} 
1.5 (1.3 - 1.8) 
1st ⁰AV block (%) 11.4 (6.9 - 16.9)*** 
[2; 483] {65%} 
1.1 (0.25 - 2.5) 
[4; 5991] {92%} 
11.6 (8.0 – 17.0) 
Incomplete RBBB (%) 22.1 (13.1 -  32.7) 
[3; 525] {83%} 
21.1 (15.0 -  27.9) 
[5; 6197] {97%} 
1.1 (0.9 - 1.3) 
LVH (%) 60.3 (11.0 - 98.3)*** 
[3; 525] {99%} 
28.1 (20.2 - 36.7) 
[5; 6197] {97%} 
3.9 (3.3 - 4.7) 
ER (%) 74.3 (41.0 - 96.6)*** 
[3; 525] {98%} 
31.0 (17.4 - 46.5) 
[5; 6197] {99%} 
6.4 (5.2 – 7.9) 
Group 2 ECG patterns Risk Ratio 
TWI (≥1mm) (%) 23.4 (19.8 – 27.1)*** 
[3; 512] {69%} 
5.9 (5.3 - 6.6) 
[5; 5263] {71%} 
4.0 (3.3 – 4.8) 
Deep TWI (≥2mm) (%) 10.6 (5.5 -17.2)*** 
[3; 525] {73%} 
4.2 (0.7 - 10.4) 
[4; 3936] {97%} 
2.6 (1.9 – 3.4) 
Anterior (%) 12.2 (8.2 -16.9)*** 
[3; 512] {43%} 
4.2 (3.0 - 5.6) 
[4; 6063] {25%} 
2.9 (2.2 – 3.8) 
Anterior 
Extended (%) 
10.8 (7.8 -14.2)*** 
[2; 358] {0%} 
0.3 (0.03 - 0.8) 
[3; 3298] {66%} 
36 (18 – 71) 
Infero-lateral 
(%) 
8.2 (6.0 - 10.7)*** 
[3; 512] {95%} 
1.3 (0.3 - 3.1) 
[4; 6063] {0%} 
6.5 (4.5 – 9.3) 
Abnormal Q waves (%) 0.5 (0.0  - 2.0)* 
[3; 526] {52%} 
0.1 (0.04 - 0.3) 
[4; 6135] {19%} 
5.0 (1.3 - 19.3) 
LAE (%) 5.7 (1.2 - 1.3)*** 
[4; 680] {91%} 
2.0 (0.02 - 7.0) 
[4; 3936] {97%} 
2.9 (2.0 - 4.2) 
LAD (%) 0.8 (0.0 - 3.1) 
[2; 484] {70%} 
0.7 (0.4 - 0.9) 
[2; 3668] {0%} 
1.3 (0.4 - 3.6) 
Complete RBBB (%) 0.3 (0.02 - 1.1) 
[2; 483] {0%} 
0.3 (0.2 -0.6) 
[4; 5991] {46%} 
1.2 (0.3 – 5.0) 
Long QT (%) 1.1 (0.03 - 3.7) 
[3; 638] {79%} 
0.1 (0.0 - 0.2) 
[4; 5991] {0%} 
16.4 (4.8 – 56.0) 
Data are presented mean or percentage (95%CI) [number of articles; number of participants] 
{heterogeneity} 
*p ≤0.05 Significantly greater or more prevalent in black than Caucasian athletes  
 **p ≤0.01 Significantly greater or more prevalent in black than Caucasian athletes  
*** p ≤0.001 Significantly greater or more prevalent in black than Caucasian athletes 
Abbreviations: LVH: left ventricular hypertrophy; TWI: T-wave inversion; Anterior: V1–V3; Extended 
Anterior: V1–V4; Infero-lateral: Leads II-aVF/V4-V6/I-aVL. 
 
  
Table 5 Echocardiographic patterns of Paediatric Athletes and Paediatric Non-athletes 
Parameter Athletes Non-athletes % Difference 
LVIDd (mm) 47.3 (46.2 - 48.3)***  
[33; 6681] {99%} 
43.4 (41.7 - 45.1) 
[18; 1042] {98%} 
8.2 
LVIDs (mm) 29.6 (28.4 - 30.8)***  
[19; 3354] {98%} 
25.4 (24.8 - 26.0)  
[7; 177] {64%} 
14.2 
IVSd (mm) 8.5 (8.2 - 8.8)***  
[28; 5083] {99%} 
7.4 (7.1 - 7.8) 
[16; 804] {98%} 
12.9 
PWTd (mm) 8.2 (7.8 - 8.6)** 
[29; 5168] {99%} 
7.2 (6.6 - 7.8) 
[17; 908] {92%} 
12.2 
RWT 0.36 (0.34 - 0.37)***  
[29; 6315] {99%} 
0.34 (0.33 - 0.35) 
[16; 804] {99%} 
5.6 
LVM (g) 135.7 (122.2 - 149.1)***  
[29; 5086] {99%} 
98.2 (84.6 - 111.8) 
[17; 908] {99%} 
27.6 
LVEDV (ml) 106.8 (91.8 - 121.8) 
[6; 494] {98.3%} 
  
LVESV (ml) 38.3 (35.1 - 41.6) 
[5; 457] {86%} 
  
Aortic Root (mm) 26.3 (24.9 - 27.8)*  
[10; 3055] {99%} 
23.5 (20.9 - 26.0) 
[6; 563] {99%} 
10.6 
LAD (mm) 30.2 (28.7 - 31.7)*  
[13; 5324] {99%} 
26.5 (24.5 - 28.6) 
[8; 587] {97%} 
12.3 
EF (%) 65.6 (61.1 - 70.1) 
[11; 3150] {99%} 
70.9 (63.8 - 77.9) 
[4; 130] {99%} 
-8.1 
FS (%) 37.2 (35.5 - 38.9) 
[14; 1829] {98%} 
36.9 (34.7 - 39.1) 
[11; 666] {96%} 
0.8 
E Wave (m/s) 0.88 (0.81 - 0.96) 
[10; 1915] {0%} 
0.91 (0.86 - 0.96) 
[4; 480] {93%} 
-3.4 
A Wave (m/s) 0.46 (0.43 - 0.49) 
[10; 1915] {98%} 
0.49 (0.46 - 0.52) 
[4; 480] {84%} 
-6.5 
E/A ratio 2.1 (2.0 - 2.2) 
[14; 3634] {96%} 
1.9 (1.8 - 2.1) 
[8; 672] {93%} 
9.5 
DT (ms) 133 (108 -  157) 
[4; 201] {97%} 
  
IVRT (ms) 60 (39 - 82) 
[3; 168] {99%} 
  
 Data are mean (95% CI), [number of studies; number of participants] {heterogeneity}  
*p ≤0.05 Significantly greater in athletes than non-athletes 
 **p ≤0.01 Significantly greater in athletes than non-athletes 
*** p ≤0.001 Significantly greater in athletes than non-athletes 
LVIDd, left ventricular cavity diameter in end-diastole; LVIDs, left ventricular cavity diameter in end-
systole; IVSd, interventricular septum thickness in end-diastole; PWTd, posterior wall thickness in end-
diastole; RWT, relative wall thickness; LVM, left ventricular mass; LVEDV, left ventricular end-diastolic 
volume; LVESV, left ventricular end-systolic volume; Ao, aortic root diameter; LAD, left atrial diameter; 
EF, ejection fraction; FS, fractional shortening; DT, Deceleration time; IVRT, interventricular septum 
relaxation time 
  
 Table 6 Echocardiographic patterns of Paediatric Athletes: Impact of Age  
Parameter ≥14 years ˂14 years % Difference 
LVIDd (mm) 51.2 (50.6 - 51.9)** 
[14; 2856] {93%} 
44.3 (43.3 - 45.3)  
[14; 872] {94%} 
13.5 
LVIDs (mm) 32.8 (30.8 - 34.7)**  
[5; 288] {97%} 
27.6 (25.9 - 29.2)  
[8; 363] {98%} 
15.9 
IVSd (mm) 9.2 (8.8 - 9.6)**  
[12; 1366] {97%} 
7.8 (7.5 - 8.0)  
[13; 787 {96%} 
15.2 
PWTd (mm) 8.9 (8.5 - 9.3)**  
[12; 1378] {98%} 
7 (6.6 - 7.3)  
[14; 872] {0%} 
21.3 
RWT 0.36 (0.33 - 0.39)  
[12; 2857] {99%} 
0.35 (0.33 - 0.36)  
[13; 787] {96%} 
2.8 
LVM (g) 167 (153.5 - 180.4)** 
[12; 1378] {96%} 
102.3 (91.8 - 112.8) 
[14; 872] {87%} 
38.7 
 
Ao (mm) 28.9 (27.3 - 30.4)**  
[5; 2396] {98%} 
24.8 (23.7 - 25.8)  
[6 2420] {97%} 
14.2 
LAD (mm) 33.3 (32.0 - 34.5)**  
[6; 2462]  {95%} 
28.1 (27.0 - 29.2)  
[8; 601] {93%} 
15.6 
EF (%) 63.7 (59.1 - 68.2) 
[4; 285] {99%} 
67.5 (55.2 - 79.8) 
[4; 217] {99%} 
-6.0 
FS (%) 35.8 (33.0 - 38.7) 
[3; 1052] {98%} 
38.1 (37.0 - 39.2) 
[6; 226] {56%} 
-6.4 
E Wave (m/s) 0.86 (0.83 - 0.90) 
[10; 1915] {92%} 
0.72 (0.56 - 0.88) 
[4; 480] {99%} 
16.3 
A Wave (m/s) 0.43 (0.39 - 0.46) 
[10; 1915] {95.3%} 
  
E/A ratio 2.2 (2.1 - 2.3)* 
[9; 2710] {92%} 
1.9 ( 1.9 – 2.0) 
[5; 530] {77%} 
13.6 
 Data are mean (95% CI), [number of studies; number of participants] {heterogeneity}  
*p ≤0.05 Significantly greater in athletes ≥14 years than in athletes ˂14 years 
 ** p ≤0.001 Significantly greater in athletes ≥14 years than in athletes ˂14 years 
LVIDd, left ventricular cavity diameter in end-diastole; LVIDs, left ventricular cavity diameter in end-
systole; IVSd, interventricular septum thickness in end-diastole; PWTd, posterior wall thickness in 
end-diastole; RWT, relative wall thickness; LVM, left ventricular mass; Ao, aortic root diameter; LAD, 
left atrial diameter; EF, ejection fraction; FS, fractional shortening. 
 
  
Table 7 Echocardiographic patterns of Paediatric Athletes: Impact of race  
Parameter Black (12-18 years) Caucasian (8-18 years) % Diff 
LVIDd (mm) 49.5 (47.0 - 51.9) 
[3; 525] {97%} 
48.2 (46.3 – 50.0) 
[10; 3919] {99%} 
2.6 
IVSd (mm) 9.7 (9.5 - 9.9) 
[2; 196] {0%} 
8.7 (8.0 - 9.3) 
[9; 3016] {99%} 
10.3 
PWTd(mm) 9.7 (9.4 - 10.1)* 
[2; 196] {44%} 
8.5 (7.9 - 9.0) 
[9; 3016] {99%} 
12.4 
RWT 0.39 (0.38 - 0.40) 
[4; 680] {90%} 
0.36 (0.34 - 0.38) 
[10; 3919]{ 99%} 
7.7 
LVM (g) 169.4 (143 - 195.9)  
[2; 196] {95%} 
148.2 (129.0 -167.4)  
[9; 3016] {99%} 
12.5 
Aortic Root (mm) 29.7 (28.9 - 30.5) 
[3; 638] {90%} 
26.9 (24.1 - 29.7) 
[4; 1137] {99%} 
9.4 
LAD(mm) 35.4 (34.6 - 36.1)** 
[3; 638] {81%} 
30.5 (27.0 – 34.0) 
[4; 3320] {99%} 
13.4 
E/A 2.1 (1.9 - 2.3) 
[2; 483] {88%} 
2.1(1.9 - 2.3) 
[5; 1207] {93%} 
0.0 
Data are mean (95% CI), [number of studies; number of participants]   
*p ≤0.05 Significantly greater in black than Caucasian athletes 
 **p ≤0.01 Significantly greater in black than Caucasian athletes 
LVIDd, left ventricular cavity diameter in end-diastole; IVSd, interventricular septum thickness in end-
diastole; PWTd, posterior wall thickness in end-diastole; RWT, relative wall thickness; LVM, left 
ventricular mass; Ao, aortic root diameter; LAD, left atrial diameter. 
 
 
 
 
 
 
 
  
 Table 8 Echocardiographic patterns of Paediatric Athletes: Impact of sex 
Parameter Male (8-18 years) Female (10-18 years) % Diff 
LVIDd (mm) 47.8 (46.5 - 49.2)  
[21; 4294] {99%} 
45.3 (43.5 - 47.1) 
[6; 479] {98%} 
5.2 
LVIDs (mm) 30.2 (28.5 - 31.8) 
[12; 2879] {99%} 
28.5 (25.2 - 31.9) 
[3; 92] {98%} 
5.6 
IVSd (mm) 8.7 (8.3 - 9.1)* 
[19; 4066] {99%} 
7.9 (7.5 - 8.4) 
[6; 452] {96%} 
9.2 
PWTd (mm) 8.4 (7.8 - 8.9) 
[19; 4066] {99%} 
7.8 (6.9 - 8.7) 
[6; 452] {99%} 
7.1 
RWT 0.36 (0.34 - 0.38) 
[19; 4066] {99%} 
0.34 (0.33 0.36) 
[6; 452] {95%} 
5.6 
LVM (g) 137.5 (115.3 - 159.6)  
[14; 3482] {99%} 
129.5 (99.8 - 159.2) 
[5; 298] {98%} 
5.8 
EDV (ml) 114.3 (108.0 - 120.7) 
[5; 409] {86%} 
82.2 (69.0 - 95.4) 
[2; 85] {94%} 
28 
Data are mean (95% CI), [number of studies; number of participants]   
*p ≤0.05 Significantly greater in Male than Female athletes 
 LVIDd, left ventricular cavity diameter in end-diastole; LVIDs, left ventricular cavity diameter in end-sytsole; 
IVSd, interventricular septum thickness in end-diastole; PWTd, posterior wall thickness in end-diastole; 
RLVWT, relative left ventricular wall thickness; LVM, left ventricular mass; LVEDV, left ventricular end-
diastolic volume. 
 
 
  
  
 
 
 
 
 
  
ONLINE APPENDIX 
Supplementary appendix A 
Full search strategy as applied to the MEDLINE electronic database 
 
# Query Results 
1 Adolescent/ or Child/ or Paediatrics/ 2340649 
2 (Girl* OR Boy* OR Junior* OR Juvenile* OR Teen* OR Paediatric* OR Prepubescent OR 
Pubescent OR Peri Pubertal).ti,ab,kw. 
316474 
3 Athlete/ 4416 
4 (Athlete* or Players).ti,ab,kw. 52511 
5 Electrocardiography/ 169256 
6 (Electrocardiogram* or 12 Lead Electrocardiogram* or ECG* or 12 Lead ECG* or EKG* or 
12 Lead EKG*).ti,ab,kw. 
81490 
7 Echocardiography, Doppler/ or Echocardiography, Doppler, Color/ or Echocardiography/ 
or Echocardiography, Transesophageal/ or Echocardiography, Doppler, Pulsed/ 
103453 
 
8 (Echocardiogram* or Speckle Tracking or STE Resolution or 2D STE or 2DSTE or Speckle 
or STE).ti,ab,kw. 
21310 
9 Magnetic Resonance Imaging/ 304307 
10 (MRI* or CMRI*).ti,ab,kw. 162605 
11 Ultrasonography/ or Ultrasonography, Doppler/ or Blood Flow Velocity/ 52496 
12 Ultrasound.ti,ab,kw. 167633 
13 Ventricular Function/ or Hypertrophy, Right Ventricular/ or Ventricular Function, Left/ or 
Ventricular Function, Right/ or Ventricular Septum/ or Hypertrophy, Left Ventricular/ or 
Ventricular Remodeling/ or Myocardial Contraction/ or Heart Atria/  
130852 
14 (Ventric* or Atria* or Atrium or Septum).ti,ab,kw. 443254 
15 Arteries/ or Brachial Artery/ or Radial Artery/ or Carotid Artery/ or Femoral Artery/ or 
Popliteal Artery/ or Vasodilation/ or Vasoconstriction/ or Vascular Resistance/ or Muscle 
Smooth, Vascular/ or Endothelium, Vascular/ or Arterioles/ 
282428 
16 (Artery Structure or Artery Function or Arteriolar or Conduit Artery or Resistance Artery 
or Arterial Size or Arterial Wall Thickness or Intima Media Wall Thickness or Arterial 
Remodeling or Lumen Dimension or Vascular Function or FMD or Flow Mediated 
Dilation or Flow Mediated Dilatation or Shear Stress or Shear Pattern or Shear 
Rate).ti,ab,kw. 
36920 
 
17 (Heart rate or HR or PR Interval or QT Interval or QTc or QRS Duration or QRS or LVH or 
RVH or Sokolow or Cornell or Pediatric Specific or Romhilt Estes or Early Repolarization 
or ER or ST Elevation or J Point Elevation or J Wave* or ST Segment Elevation or QRS 
Slurring or Incomplete Right Bundle Branch Block or Incomplete RBBB or Incomplete Left 
Bundle Branch Block or Incomplete LBBB or T Wave Inversion or TWI or First Degree 
Atrio Ventricular Block or 1st Degree AV Block or Q Wave* or LAE or RAE or Left Atrial 
Enlargement or Right Atrial Enlargement or Bradycardia or Arrhythmia or Ectopic Atrial 
Rhythm or Junctional Rhythm or Mobitz Type I or Mobitz I or Wenckebach or Second 
Degree AV Block or 2nd Degree AV Block or Premature Ventricular Contraction* or PVC* 
or ESC Criteria or European Society of Cardiology Recommendation or Seattle Criteria or 
Refined Criteria or ECG Criteria).ti,ab,kw. 
417843 
18 OR/1-2 2470231 
19 OR/3-4 53440 
20 OR/5-12 842415 
21 OR/13-17 1096521 
22 AND/18-21 433 
 
Supplementary appendix B 
ePublication lists of key journals hand searched to supplement electronic database searching.  
 
# Journal Yield 
1 Journal of the American College of Cardiology 0 
2 Circulation 0 
3 Circulation: Arrhythmia and Electrophysiology 0 
4 Circulation: Cardiovascular Imaging 0 
5 European Heart Journal 0 
6 European Heart Journal: Cardiovascular Imaging 0 
7 American Heart Journal 0 
8 Chest 0 
9 Heart 0 
10 British Journal of Sports Medicine 1 
11 Nature Cardiology  0 
12 The New England Journal of Medicine 0 
13 European Journal of Preventive Cardiology  0 
14 Journal of Electrocardiology  0 
15 Journal of the American Society of Echocardiography  2 
16 Scandinavian Journal of Sports Medicine  2 
17 Europace  1 
18 European Journal of Applied Physiology  2 
19 Pediatric Exercise Science  0 
20 Pediatric Cardiology  1 
21 Cardiology in the Young  1 
22 Pediatrics  0 
23 European Journal of Pediatrics  1 
24 American Journal of Hypertension 1 
25 The Journal of Physiology 0 
26 Journal of Applied Physiology 0 
Total  12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Supplementary appendix C 
15-item risk of bias assessment checklist  
Study: _______________________________________________________________________________ 
# RISK OF BIAS ASSESSMENT ITEM YES NO/UNCLEAR 
1 Sufficient power to detect clinically important effect where probability for 
difference being due to chance ˂ 5% (answer yes if sample size calculated and 
adequate to detect clinically important effect) 
  
2 Are the inclusion and exclusion criteria clearly stated?   
 Test-control 
3 Are activity levels for the control group reported?   
4 Are the control group matched for age?   
5 If groups are unmatched, have statistical differences been controlled for? (Answer 
yes if groups matched for age) 
  
 Test-athletes 
6 Are athletes of competitive status? 
"One who participates in an organised team or individual sport that requires 
regular  competition against others as a central component places a high  premium 
on excellence and achievement, and requires some  form of systematic (and usually 
intense) training" 
  
7 Are training details available? (years, volume, duration/intensity)   
 Data acquisition 
8 Is there detailed information to allow replication? (Answer yes if professional 
guidelines cited)  
  
9 Are the observer(s) stated?   
10 Are more than one observer used? If so is interobserver variability stated?   
 Measurement technique 
11 Are professional guidelines observed/cited   
 Reporting Data  
12 Is an explanation for missing data given? (Score yes if none missing)    
13 Is data clearly and accurately presented? (Simple outcome data, including 
denominators and numerators, should be reported for all major findings) 
  
14 Estimates of random variability in data provided for main outcomes? (e.g. 
interquartile range, standard error, standard deviation, confidence intervals) 
  
15 Are anthropometrics reported? (Height and weight or BSA (with formula 
presented)) 
  
 Total Score   
 
Note:  
Items 1,2,14 were selected from Downs & Black’s Assessment of Methodological Quality of Randomised and Non-
Randomised Studies checklist1. 
Items 3-5,7,10-13 were selected from a previously published athletes heart meta-analysis checklist2. 
Items 6,9,15 were written specifically for the purposes of this review.  
 
 
  
Supplementary appendix D 
Variables extracted for analysis  
 
Primary Variables ECG  Characteristics  Group 1: common and training-related ECG 
changes 
Group 2: uncommon and training-
unrelated ECG changes  
 Heart rate, bpm 
PR interval, ms 
QRS duration, ms 
QTc duration, ms 
QRS axis, degree 
S V1 + R V5/6, mm 
Sinus bradycardia (≥30 bpm) 
Sinus arrhythmia 
1st degree AV block (PR interval>200 ms) 
Morbitz type 1 (Wenckeback) 2nd degree AV 
block 
Incomplete RBBB (QRS duration, 120 ms) 
Early repolarisation (ST elevation, J-point 
elevation, J waves, notching or terminal 
QRS slurring)  
Isolated QRS voltage criteria for LVH (Sokolow-
Lyon) 
T-wave inversion 
ST-segment depression 
Pathological Q waves 
Left atrial enlargement 
Left axis deviation 
Right axis deviation 
Complete LBBB or RBBB 
Long QT interval  
Ventricular pre-excitation  
Brugada-like early repolarization 
Echo parameters Structure Function 
 LV end-diastolic internal diameter, mm 
LV end-systolic internal diameter, mm 
LV end-diastolic volume, ml 
LV end-systolic volume, ml 
Interventricular septal wall thickness, mm 
Posterior wall thickness, mm 
Maximal wall thickness, mm 
Relative wall thickness. 
Ejection fraction, % 
Fractional shortening, % 
Stoke volume, ml 
Cardiac output, lpm 
E wave (m/s) 
A wave (m/s) 
E/A 
Aortic root, mm 
RV end-diastolic area, cm2 
RV basal dimension, mm 
RV mid-ventricular dimension 
RV longitudinal dimension 
RV outflow tract dimension (parasternal), mm 
RV outflow tract dimension (proximal), mm 
RV outflow tract dimension (distal), mm 
RV free wall thickness, mm 
Left atrial diameter, mm 
LV mass, grams 
Secondary 
Variables  
Contextual Factors  
  Age range 
Gender 
Ethnicity 
Height, cm 
Weight, kg 
BSA 
Sport 
Training Hours/Week, hours 
Training Years, years 
Bpm: beats per minute; ms: milliseconds; mm; millimeters; cm; centimeters; LBBB: left bundle branch block; RBBB: right bundle branch block; LVH: left ventricle 
hypertrophy; LV: left ventricle; RV: right ventricle; m/s: meters per second; kg: kilograms; BSA: body surface area.  
 
  
Supplementary appendix E 
Risk of bias assessment  
 
 
 
 
 
Article 
Criterion 1 Criterion 2 Criterion 3 Criterion 4 Criterion 5 Criterion 6 Criterion 7 Criterion 8 
Power 
analysis  
Selection 
criteria 
Nonathlete 
activity levels 
Control 
age matched 
Statistical 
differences 
accounted for 
Competitive 
athletes 
Athlete training 
details 
Detailed data 
acquisition 
Agrebi 20153  N Y N N N Y Y N 
Attisani 20114 N Y N N N Y N N 
Ayabakan 20065 N Y Y Y Y Y Y Y 
Bartkevičienė 20156 N Y Y Y Y Y Y Y 
Bessem 20147 N Y N N N Y N Y 
Calò 20158 N Y N N N Y Y Y 
Csajági 20159 N Y Y Y Y Y Y Y 
Di Paolo 201210 N Y N N N Y Y Y 
Dinu 201011 N N Y Y Y Y N N 
Hauser 201312 N Y N N N Y Y Y 
Hoogsteen 200313 N Y N N N Y Y Y 
Kinoshita 201514 N Y N N N Y Y Y 
Koch 201215 N Y N N N Y Y Y 
Konopka 201516 N Y N N N Y Y Y 
Madeira 200817 N Y N N N Y Y Y 
Makan 200518 N Y Y Y Y Y Y Y 
Medved 198619 N Y Y Y Y Y Y Y 
Meško 199320 N Y Y Y Y Y Y Y 
Migliore 201221 N Y N N N Y N Y 
Moarles 199222 N Y N N N Y N Y 
Obert 199823 N Y Y Y Y Y Y Y 
Ozer 199424 N Y Y Y Y Y Y Y 
Papadakis 200925 N Y Y Y Y Y Y Y 
Pavlik 200126 N Y N N Y Y Y Y 
Pelà 201427 N Y N N N Y Y Y 
Pelà 2015 28 N Y N N N Y Y Y 
Petridis 200429 N Y N Y Y Y Y Y 
Rowland 1987 30 N Y Y Y Y Y Y Y 
Rowland 199431 N Y N Y Y Y Y Y 
Rowland 199732 N Y N N N Y Y Y 
 
 
 
Article 
 
Criterion 1 Criterion 2 Criterion 3 Criterion 4 Criterion 5 Criterion 6 Criterion 7 Criterion 8 
Power 
analysis 
Selection 
criteria 
Nonathlete 
activity levels 
Non-athlete 
age matched 
Statistical 
differences 
accounted for 
Competitive athletes Athlete training 
details 
Detailed data 
acquisition 
Rowland 200033 N Y Y Y Y Y Y Y 
Schmied 200934 N Y N N N Y N Y 
Sharma 199935 N Y Y Y Y Y Y Y 
Sharma 200236 N Y Y Y Y Y Y Y 
Sheikh 201337 N Y Y Y Y Y N Y 
Shi & Selig 200538 N Y Y Y Y Y Y Y 
Stoner 199739 N Y Y Y Y Y Y Y 
Sundberg & Elovainio 
198240 
N Y N Y Y Y Y Y 
Telford 198841 N Y Y Y Y Y Y Y 
Valente-Dos-Santos 
201342 
N Y N N N Y Y Y 
Vasiliauskas 200643 N Y N N N Y Y Y 
Yildirim 201644 N Y Y Y Y Y Y Y 
Zdravkovic 2010 45 N Y Y Y Y Y Y Y 
No. of articles 
fulfilling each 
criterion (% of total 
included studies) 
0(0%) 42(98%) 19(44%) 23(53%) 24(56%) 42(100%) 36(84%) 40(93%) 
Proportions of 
agreement 
100%(90-
100) 
88%(74-96) 84%(69-93) 91%(77-97) 86%(71-94) 91%(77-97) 91%(77-97) 95%(83-99) 
Y = criterion fulfilled, N = criterion not fulfilled 
 
 
 
 
 
 
 
 
 
Article 
Criterion 9 Criterion 10 Criterion 11 Criterion 12 Criterion 13 Criterion 14 Criterion 15 Total 
Observer(s) 
stated 
Interobserver 
reliability 
Professional 
guidelines 
Missing data Data 
presentation 
Random 
variability 
Anthropometrics  
Agrebi 20153  N N Y Y Y Y Y 8 
Attisani 20114 N N N Y Y N N 4 
Ayabakan 20065 Y N Y Y Y Y Y 13 
Bartkevičienė 20156 N N Y Y Y Y Y 12 
Bessem 20147 Y N Y Y Y Y Y 9 
Calò 20158 Y N Y Y Y Y Y 10 
Csajági 20159 Y N Y Y Y Y Y 13 
Di Paolo 201210 N N Y Y Y Y Y 9 
Dinu 201011 N N N N Y Y Y 7 
Hauser 201312 Y N Y Y Y N Y 9 
Hoogsteen 200313 Y N Y N Y Y Y 9 
Kinoshita 201514 Y N Y Y Y Y Y 10 
Koch 201215 Y N Y Y Y Y Y 10 
Konopka 201516 N N Y Y Y Y Y 9 
Madeira 200817 Y N Y Y Y Y Y 10 
Makan 200518 Y N Y Y Y Y Y 13 
Medved 198619 N N Y Y Y Y N 11 
Meško 199320 N N Y Y Y Y Y 12 
Migliore 201221 Y N Y Y Y Y N 8 
Moarles 1992 22 N N Y N N N Y 5 
Obert 1998 23 Y N Y Y Y Y Y 13 
Ozer 199424 Y N Y Y Y Y N 12 
Papadakis 200925 Y N Y Y Y Y Y 13 
Pavlik 200126 Y N Y Y Y Y N 10 
Pelà 201427 Y N Y Y Y Y Y 10 
Pelà 201528 Y N Y Y Y Y Y 10 
Petridis 200429 N N Y Y Y Y Y 11 
Rowland 198730 Y N Y Y Y Y N 12 
Rowland 199431 Y N Y Y Y Y Y 12 
Rowland 199732 N N Y Y Y Y Y 9 
 
 
 
 
 
 
 
Article 
Criterion 9 Criterion 10 Criterion 11 Criterion 12 Criterion 13 Criterion 14 Criterion 15 Total 
Observer(s) 
stated 
Interobserver 
reliability 
Professional 
guidelines 
Missing data Data 
presentation 
Random 
variability 
Anthropometrics  
Rowland 200033 N N Y Y Y Y Y 12 
Schmied 200934 Y N Y Y Y Y Y 9 
Sharma 199935 N N Y Y Y Y Y 12 
Sharma 200236 Y N Y Y Y Y Y 13 
Sheikh 201337 Y N Y Y Y Y Y 12 
Shi & Selig 200538 N N Y Y Y Y Y 12 
Stoner 199739 N N Y Y Y Y Y 12 
Sundberg & Elovainio 
198240 
Y N N Y Y Y Y 11 
Telford 198841 N N Y Y Y Y Y 12 
Valente-Dos-Santos 
201342 
Y N Y Y Y Y Y 10 
Vasiliauskas 200643 Y N Y Y Y Y Y 10 
Yildirim 201644 N N Y Y Y Y Y 12 
Zdravkovic 2010 45 Y N Y Y Y Y Y 13 
No. of articles 
fulfilling each 
criterion (% of total 
included studies) 
26(60%) 0(0%) 40(93%) 40(93%) 43(98%) 40(93%) 37(86%) 452 (70%) 
Proportions of 
agreement 
81%(66-91) 100%(90-100) 77%(61-88) 77%(61-88) 84%(69-93) 93%(80-98) 88%(74-96) 70%(47-83) 
Y = criterion fulfilled, N = criterion not fulfilled 
 
 
Supplementary appendix F 
Articles with overlapping electrocardiographic data 
First Author Overlapping participants  Number of participants included  
Di Paolo 201210 Athlete (males, black; n=154) 155/155 
Schmied 200934 Athlete (males, black; n=155) 
Pelà 201528 Athlete (males, Caucasian; n=158)  158/158 
Pelà 201427 Athlete (males, Caucasian; n=96) 
 
Articles with overlapping Echocardiographic data  
First Author Overlapping participants  Number of participants included  
Di Paolo 201210 Athletes (males, black; n=154) 155/155 
Schmied 200934 Athletes (males, black; n=155) 
Makan 200518 Athletes (males, mixed race; n=693) 
Athletes (females, mixed race; n=207) 
900/900 
 
 Sharma 200236 Athletes (males, mixed race; n=540) 
Athletes (females, mixed race; n=180) 
Pelà 201528 Athletes (male, Caucasian; n=158) 158/158 
Pelà 201427 Athletes (male, Caucasian; n=96) 
 
Articles reporting repeat echocardiographic measurements (within the same article)  
First Author Follow-up Participants Number of 
participants 
included 
Csajági 20159 Six repeat assessments:  
 Start 
 Endurance (GEP1) 
 Race 1 (RP1) 
 Detraining (DT) 
 Endurance (GEP2) 
 Race2 (RP2) 
 
Athletes (mixed gender, Caucasian; n=15) 15/15 
Meško 199320 Four repeat assessments:  
 Year 1 
 Year 2 
 Year 3 
 Year 4 
Athletes (male; n=23) 
Nonathletes (males; n=17) 
40/40 
Stoner 199739 Two assessments:  
 Pre-onset of training 
 1 Year post onset of 
training  
Athletes (male; n=37) 
Nonathletes (male; n=20) 
57/57 
Kinoshita 201514 Five repeat assessments: 
 Baseline 
 0.5 Years post 
 1 Year post 
 1.5 Years post 
 2 Years post 
 2.5 Years post 
 3 Years post  
Athletes (females, Japanese; n=51) 34/51 
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